{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:03:37Z","timestamp":1790870617705,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T00:00:00Z","timestamp":1471651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00432-016-2220-6","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T07:20:25Z","timestamp":1471677625000},"page":"2239-2247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin"],"prefix":"10.1007","volume":"142","author":[{"given":"Susann","family":"Stollberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"K\u00e4mmerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Simonitsch-Klupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Lupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,20]]},"reference":[{"key":"2220_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","volume":"14","author":"F Balkwill","year":"2004","unstructured":"Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171\u2013179","journal-title":"Semin Cancer Biol"},{"key":"2220_CR2","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1158\/1078-0432.CCR-12-3015","volume":"19","author":"K Beider","year":"2013","unstructured":"Beider K, Ribakovski E, Abraham M, Wald H, Weiss L, Rosenberg E, Galun E, Avigdor A, Eizenberg O, Peled A, Nagler A (2013) Targeting the CD20 and CXCR4 pathways in non-Hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140. Clin Cancer Res 19:3495\u20133507","journal-title":"Clin Cancer Res"},{"key":"2220_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00401-007-0258-x","volume":"114","author":"A Brunn","year":"2007","unstructured":"Brunn A, Montesinos-Rongen M, Strack A, Reifenberger G, Mawrin C, Schaller C, Deckert M (2007) Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma. Acta Neuropathol 114:271\u2013276","journal-title":"Acta Neuropathol"},{"key":"2220_CR4","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.18632\/oncotarget.3343","volume":"6","author":"J Chen","year":"2015","unstructured":"Chen J, Xu-Monette ZY, Deng L, Shen Q, Manyam GC, Martinez-Lopez A, Zhang L, Montes-Moreno S, Visco C, Tzankov A, Yin L, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, His ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, Moller MB, Farnen JP, Winter JN, Piris MA, Pham L, Young KH (2015) Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal-center B-cell like diffuse large B-cell lymphoma. Oncotarget 6:5597\u20135614","journal-title":"Oncotarget"},{"key":"2220_CR5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.11-10-1100","volume":"11","author":"SM Cohen","year":"2006","unstructured":"Cohen SM, Petryk M, Varma M, Kozuch PS, Ames ED, Grossbard ML (2006) Non-Hodgkin\u2019s lymphoma of mucosa-associated lymphoid tissue. Oncologist 11:1100\u20131117","journal-title":"Oncologist"},{"key":"2220_CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000167796","volume":"89","author":"VD Corleto","year":"2009","unstructured":"Corleto VD, Falconi M, Panzuto F, Milione M, De Luca O, Perri P, Cannizzaro R, Bordi C, Pederzoli P, Scarpa A, Delle Fave G (2009) Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinol 89:223\u2013230","journal-title":"Neuroendocrinol"},{"key":"2220_CR7","first-page":"8","volume":"45","author":"VASH Dalm","year":"2004","unstructured":"Dalm VASH, Hofland LJ, Mooy CM, Waaijers MA, van Koetsveld PM, Langerak AW, Staal FTJ, van der Lely A-J, Lamberts SWJ, van Hagen MP (2004) Somatostatin receptors in malignant lymphomas: targets for radiotherapy? J Nucl Med 45:8\u201316","journal-title":"J Nucl Med"},{"key":"2220_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1748-717X-8-2","volume":"8","author":"K Deinbeck","year":"2013","unstructured":"Deinbeck K, Geinitz H, Haller B, Fakhrian K (2013) Radiotherapy in marginal zone lymphoma. Radiat Oncol 8:2","journal-title":"Radiat Oncol"},{"key":"2220_CR9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.2372","volume":"215","author":"AJA Deutsch","year":"2008","unstructured":"Deutsch AJA, Aigelsreiter A, Steinbauer E, Fr\u00fchwirth M, Kerl H, Beham-Schmid C, Schaider H, Neumeister P (2008) Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol 215:431\u2013444","journal-title":"J Pathol"},{"key":"2220_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/modpathol.2012.134","volume":"26","author":"AJA Deutsch","year":"2013","unstructured":"Deutsch AJA, Steinbauer E, Hofmann NA, Strunk D, Gerlza T, Beham-Schmid C, Schaider H, Neumeister P (2013) Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma. Modern Pathol 26:182\u2013194","journal-title":"Modern Pathol"},{"key":"2220_CR11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.leu.2402107","volume":"15","author":"J Durig","year":"2001","unstructured":"Durig J, Schmucker U, Duhrsen U (2001) Differential expression of chemokine receptors in B cell malignancies. Leukemia 15:752\u2013756","journal-title":"Leukemia"},{"key":"2220_CR12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.semnuclmed.2005.03.001","volume":"35","author":"D Ferone","year":"2005","unstructured":"Ferone D, Semino C, Boschetti M, Cascini GL, Minuto F, Lastoria S (2005) Initial staging of lymphoma with octreotide and other imaging agents. Semin Nucl Med 35:176\u2013185","journal-title":"Semin Nucl Med"},{"key":"2220_CR13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bpg.2014.09.006","volume":"28","author":"W Fischbach","year":"2014","unstructured":"Fischbach W (2014) Gastric MALT lymphoma\u2014update on diagnosis and treatment. Best Pract Res Clin Gastroentreol 28:1069\u20131077","journal-title":"Best Pract Res Clin Gastroentreol"},{"key":"2220_CR14","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1210\/jc.2008-1063","volume":"93","author":"T Fischer","year":"2008","unstructured":"Fischer T, Doll C, Jacobs S, Kolodziej A, Stumm R, Schulz S (2008a) Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1. J Clin Endocrinol Metab 93:4519\u20134524","journal-title":"J Clin Endocrinol Metab"},{"key":"2220_CR15","doi-asserted-by":"crossref","first-page":"e4069","DOI":"10.1371\/journal.pone.0004069","volume":"3","author":"T Fischer","year":"2008","unstructured":"Fischer T, Nagel F, Jacobs S, Stumm R, Schulz S (2008b) Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. PLoS ONE 3:e4069","journal-title":"PLoS ONE"},{"key":"2220_CR16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1440-1827.2010.02548.x","volume":"60","author":"B Furusato","year":"2010","unstructured":"Furusato B, Mohamed A, Uhl\u00e9n M, Rhim JS (2010) CXCR4 and cancer. Pathol Int 60:497\u2013505","journal-title":"Pathol Int"},{"key":"2220_CR17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2967\/jnumed.111.098798","volume":"52","author":"E Gourni","year":"2011","unstructured":"Gourni E, Demmer O, Schottelius M, D\u2019Alessandria C, Schulz S, Dijkgraaf I, Schumacher U, Schwaiger M, Kessler H, Wester HJ (2011) PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med 52:1803\u20131810","journal-title":"J Nucl Med"},{"key":"2220_CR18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00259-003-1206-1","volume":"30","author":"S Li","year":"2003","unstructured":"Li S, Kurtaran A, Li M, Traub-Weidinger T, Kienast O, Schima W, Angelberger P, Virgolini I, Raderer M, Dudczak R (2003) 111In-DOTA-DPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study. Eur J Nucl Med Mol Imaging 30:1087\u20131095","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2220_CR19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3892\/ol.2013.1435","volume":"6","author":"Y Liu","year":"2013","unstructured":"Liu Y, Jiang L, Mu Y (2013) Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment. Oncol Lett 6:821\u2013828","journal-title":"Oncol Lett"},{"key":"2220_CR20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1189\/jlb.1203652","volume":"76","author":"S Lopez-Giral","year":"2004","unstructured":"Lopez-Giral S, Quintana NE, Cabrerizo M, Alfonso-Perez M, Sala-Valdes M, de Soria VG, Fernandez-Ranada JM, Fernandez-Ruiz E, Munoz C (2004) Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 76:462\u2013471","journal-title":"J Leukoc Biol"},{"key":"2220_CR21","first-page":"222","volume":"42","author":"PJ Lugtenburg","year":"2001","unstructured":"Lugtenburg PJ, L\u00f6wenberg B, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, van Putten WL, Krenning EP (2001) Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin\u2019s lymphomas. J Nucl Med 42:222\u2013229","journal-title":"J Nucl Med"},{"key":"2220_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-483X(01)00333-X","volume":"161","author":"A Lupp","year":"2001","unstructured":"Lupp A, Danz M, M\u00fcller D (2001) Morphology and cytochrome P450 isoforms expression in precision-cut rat liver slices. Toxicology 161:53\u201366","journal-title":"Toxicology"},{"key":"2220_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000329876","volume":"94","author":"A Lupp","year":"2011","unstructured":"Lupp A, Hunder A, Petrich A, Nagel F, Doll C, Schulz S (2011) Reassessment of sst5 somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4. Neuroendocrinol 94:255\u2013264","journal-title":"Neuroendocrinol"},{"key":"2220_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000337659","volume":"96","author":"A Lupp","year":"2012","unstructured":"Lupp A, Nagel F, Doll C, R\u00f6cken C, Evert M, Mawrin C, Saeger W, Schulz S (2012) Reassessment of sst3 somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4. Neuroendocrinol 96:301\u2013310","journal-title":"Neuroendocrinol"},{"key":"2220_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2013.02.001","volume":"183","author":"A Lupp","year":"2013","unstructured":"Lupp A, Nagel F, Schulz S (2013) Reevaluation of sst1 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7. Regul Pept 183:1\u20136","journal-title":"Regul Pept"},{"key":"2220_CR26","doi-asserted-by":"crossref","first-page":"e98194","DOI":"10.1371\/journal.pone.0098194","volume":"9","author":"G Mazur","year":"2014","unstructured":"Mazur G, Butrym A, Kryczek I, Dlubek D, Jaskula E, Lange A, Kuliczkowski K, Jelen M (2014) Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor. PLoS ONE 9:e98194","journal-title":"PLoS ONE"},{"key":"2220_CR27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/path.4446","volume":"235","author":"MJ Moreno","year":"2015","unstructured":"Moreno MJ, Bosch R, Dieguez-Gonzalez R, Novelli S, Mozos A, Gallardo A, Pavon MA, Cespedes MV, Granena A, Alcoceba M, Blanco O, Gonzalez-Diaz M, Sierra J, Mangues R, Casanova I (2015) CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival. J Pathol 235:445\u2013455","journal-title":"J Pathol"},{"key":"2220_CR28","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/10428190310001641233","volume":"45","author":"D Morgensztern","year":"2004","unstructured":"Morgensztern D, Rosado MF, Serafini AN, Lossos IS (2004) Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab. Leuk Lymphoma 45:1275\u20131278","journal-title":"Leuk Lymphoma"},{"key":"2220_CR29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.gtc.2015.05.012","volume":"44","author":"S Nakamura","year":"2015","unstructured":"Nakamura S, Matsumoto T (2015) Treatment strategy of gastric mucosa-associated lymphoid tissue lymphoma. Gastroenterol Clin North Am 44:649\u2013660","journal-title":"Gastroenterol Clin North Am"},{"key":"2220_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4143\/crt.2014.46.1.33","volume":"46","author":"TK Nam","year":"2014","unstructured":"Nam TK, Ahn JS, Choi YD, Jeong JU, Kim YH, Yoon MS, Song JY, Ahn SJ, Chung WK (2014) The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Res Treat 46:33\u201340","journal-title":"Cancer Res Treat"},{"key":"2220_CR31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2141.2011.08841.x","volume":"155","author":"U Novak","year":"2011","unstructured":"Novak U, Basso K, Pasqualucci L, Dalla-Favera R, Bhagat G (2011) Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells. Br J Haematol 155:362\u2013365","journal-title":"Br J Haematol"},{"key":"2220_CR32","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1039\/c2ob25107h","volume":"10","author":"S Oishi","year":"2012","unstructured":"Oishi S, Fujii N (2012) Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4). Org Biomol Chem 10:5720\u20135731","journal-title":"Org Biomol Chem"},{"key":"2220_CR33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","volume":"119","author":"AJ Olszewski","year":"2013","unstructured":"Olszewski AJ, Castillo JJ (2013) Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology, and end results database. Cancer 119:629\u2013638","journal-title":"Cancer"},{"key":"2220_CR34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/jnci\/91.8.716","volume":"91","author":"M Raderer","year":"1999","unstructured":"Raderer M, Valencak J, Pfeffel F, Drach J, Pangerl T, Kurtaran A, Hejna M, Vorbeck F, Chott A, Virgolini I (1999) Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type. J Natl Cancer Inst 91:716\u2013718","journal-title":"J Natl Cancer Inst"},{"key":"2220_CR35","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1054\/bjoc.2001.2070","volume":"85","author":"M Raderer","year":"2001","unstructured":"Raderer M, Traub T, Formanek M, Virgolini I, \u00d6sterreicher C, Fiebiger W, Penz M, J\u00e4ger U, Pont J, Chott A, Kurtaran A (2001) Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type. Br J Cancer 85:1462\u20131466","journal-title":"Br J Cancer"},{"key":"2220_CR36","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","volume":"11","author":"M Raderer","year":"2005","unstructured":"Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, Chott A (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11:3349\u20133352","journal-title":"Clin Cancer Res"},{"key":"2220_CR37","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2006.06.0723","volume":"24","author":"M Raderer","year":"2006","unstructured":"Raderer M, W\u00f6hrer S, Streubel B, Troch M, Turetschek K, J\u00e4ger U, Skrabs C, Gaiger A, Drach J, Puespoek A, Formanek M, Hoffmann M, Hauff W, Chott A (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24:3136\u20133141","journal-title":"J Clin Oncol"},{"key":"2220_CR38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3322\/caac.21330","volume":"66","author":"M Raderer","year":"2016","unstructured":"Raderer M, Kiesewetter B, Ferreri AJ (2016) Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin 66:152\u2013171","journal-title":"CA Cancer J Clin"},{"key":"2220_CR39","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138\u2013140","journal-title":"Pathologe"},{"key":"2220_CR40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ijc.2910500613","volume":"50","author":"JC Reubi","year":"1992","unstructured":"Reubi JC, Waser B, van Hagen MS, Lamberts WJ, Krenning EP, Gebbers J-O, Laissue AJ (1992) In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 50:895\u2013900","journal-title":"Int J Cancer"},{"key":"2220_CR41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3904\/kjim.2014.29.6.785","volume":"29","author":"HC Shin","year":"2014","unstructured":"Shin HC, Seo J, Kang BW, Moon JH, Chae YS, Lee SJ, Lee YJ, Han S, Seo SK, Kim JG, Sohn SK, Park T-I (2014) Clinical significance of nuclear factor \u03baB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy. Korean J Intern Med 29:785\u2013792","journal-title":"Korean J Intern Med"},{"key":"2220_CR42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MPA.0000000000000493","volume":"45","author":"KB Song","year":"2016","unstructured":"Song KB, Kim SC, Kim JH, Seo D-W, Hong S-M, Park K-M, Hwang DW, Lee JH, Lee Y-J (2016) Prognostic value of somatostatin receptor subtypes in pancreatic neuroendocrine tumors. Pancreas 45:187\u2013192","journal-title":"Pancreas"},{"key":"2220_CR43","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res 16:2927\u20132931","journal-title":"Clin Cancer Res"},{"key":"2220_CR44","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3109\/10428194.2012.754023","volume":"54","author":"K Ueda","year":"2013","unstructured":"Ueda K, Terui Y, Yokoyama M, Sakajiri S, Nishimura N, Tsuyama N, Takeuchi K, Hatake K (2013) Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy. Leukemia & Lymphoma 54:1928\u20131933","journal-title":"Leukemia & Lymphoma"},{"key":"2220_CR45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/thno.11251","volume":"5","author":"HJ Wester","year":"2015","unstructured":"Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F, Simecek J, Gerngross C, Lassmann M, Herrmann K, Pellegata N, Rudelius M, Kessler H, Schwaiger M (2015) Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics 5:618\u2013630","journal-title":"Theranostics"},{"key":"2220_CR46","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00277-014-2042-z","volume":"93","author":"S W\u00f6hrer","year":"2014","unstructured":"W\u00f6hrer S, Kiesewetter B, Fischbach J, M\u00fcllauer L, Troch M, Lukas J, Mayerhofer ME, Raderer M (2014) Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a songle-center analysis. Ann Hematol 93:1287\u20131295","journal-title":"Ann Hematol"},{"key":"2220_CR47","doi-asserted-by":"crossref","unstructured":"Zucca E, Copie-Bergmann C, Ricardi U, Thieblemont C, Raderer M, Ladetto M, on behalf of the ESMO Guidelines Working Group (2013) Gastric marginal zone lymphoma of the MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi144\u2013vi148","DOI":"10.1093\/annonc\/mdt343"},{"key":"2220_CR48","first-page":"1","volume":"27","author":"A Zullo","year":"2014","unstructured":"Zullo A, Hassan C, Repici A, Manta R, Andriani A (2014) Gastric MALT lymphoma: old and new insights. Ann Gastroenterol 27:1\u20137","journal-title":"Ann Gastroenterol"}],"updated-by":[{"DOI":"10.1007\/s00432-016-2312-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000}}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-016-2220-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T16:27:35Z","timestamp":1568305655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-016-2220-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s00432-016-2220-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00432-016-2312-3","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,20]]}}}